Trials / Unknown
UnknownNCT05543772
Evaluation of Blood Sampling From a Pre-existed Peripheral Intravenous Catheter Line
Evaluation of Blood Sampling From a Pre-existed Peripheral Intravenous Catheter Line (Indwelling Line): a Technique to Keep Optimal Specimen After Fluid Flush
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Imam Abdulrahman Bin Faisal University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Background: Peripheral Intravenous catheter (PIVC) is a frequently used device for intravascular access. It is usually indicated to administer intravenous fluid and medications. However, the investigators could possibly utilize this line for blood sampling even after using it as a fluid port.
Detailed description
Aims: To investigate the quality of previously flushed PIVC sample and the effectiveness of the withdrawal technique. Methodology: Study will be held in King Fahad University Hospital during a year after obtaining the IRB approval. Selection of study participants will be depending on their health status and the investigators will exclude pediatric participants. Two blood samples will be collected from participants. First one is after the insertion of the intravenous peripheral line. The second is after fluid infusion through the same line. Samples will be sent to the laboratory then. Results will be collected and analyzed. The importance of the research: If this type of sampling can be standardized , this means there will be less insertions to the patients, less adverse effects in relation to the number of insertions, fast and preexisted intravascular access for sampling so the time can be saved in critical conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Normal saline | participant will be given 500 ml normal saline through intravenous access. blood sample will be extracted before and after giving normal saline using same intravenous catheter |
Timeline
- Start date
- 2023-09-01
- Primary completion
- 2024-09-01
- Completion
- 2024-09-01
- First posted
- 2022-09-16
- Last updated
- 2023-10-16
Locations
1 site across 1 country: Saudi Arabia
Source: ClinicalTrials.gov record NCT05543772. Inclusion in this directory is not an endorsement.